SUVs on FDG-PET/CT provide clues on head, neck cancer recurrence

11/22/2009 | (free registration)

A study of patients with head and neck squamous cell cancer found that higher standardized uptake values, or SUVs, on FDG-PET/CT scans after treatment can be linked to the risk of cancer recurrence. "We were interested to know whether PET scans could help predict which patients might respond better by scanning them early in the course of treatment," said the study's lead author.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC